4.7
Chronische obstructieve longziekte III: Kenmerken van chronische bronchitis
Chronische bronchitis is een belangrijk fenotype van chronische obstructieve longziekte, of COPD, gekenmerkt door luchtweggerichte ontsteking en overm…
Chronic bronchitis, a major phenotype of COPD, results from prolonged exposure to airborne irritants such as cigarette smoke.
These irritants trigger persistent inflammation that begins in the larger bronchi and extends into the smaller airways.
Neutrophils, macrophages, and lymphocytes infiltrate the bronchial walls, causing epithelial injury.
Inflammation also causes squamous metaplasia, which replaces the ciliated epithelium with squamous cells, impairing mucociliary clearance.
Meanwhile, goblet cells and submucosal glands undergo hyperplasia and hypertrophy, producing thick mucus that clogs the airways and promotes infection.
Persistent inflammation and mucus plugging lead to airway remodeling, including smooth muscle hypertrophy and fibrosis, which narrow the airways, especially during expiration.
Airway obstruction creates a ventilation–perfusion mismatch, leading to hypoxemia. Progressive air trapping causes hyperinflation, which flattens the diaphragm, reduces ventilatory efficiency, and increases the work of breathing.
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic bronchitis to develop?
Chronic bronchitis develops from prolonged exposure to airborne irritants, most commonly cigarette smoke. These irritants trigger persistent inflammation that begins in the larger bronchi and extends into smaller airways. Neutrophils, macrophages, and lymphocytes infiltrate the bronchial walls, causing epithelial injury and initiating a cascade of structural and functional changes.
Q2: How does squamous metaplasia affect the airways in chronic bronchitis?
Squamous metaplasia replaces the ciliated epithelium with non-ciliated squamous cells, impairing mucociliary clearance. This loss of ciliated cells reduces the airway's ability to trap and remove mucus and pathogens, increasing infection risk and allowing mucus to accumulate and damage airways progressively.
Q3: Why do goblet cells and submucosal glands enlarge in chronic bronchitis?
Persistent inflammation triggers hyperplasia and hypertrophy of goblet cells and submucosal glands. These enlarged structures produce excessive, thick mucus that clogs airways and promotes bacterial colonization. The increased Reid index reflects glands occupying over half the bronchial wall thickness, contributing to airflow obstruction.
Q4: What is the relationship between airway remodeling and breathing difficulty?
Airway remodeling includes smooth muscle hypertrophy, fibrosis, and inflammatory thickening that narrow airways, especially during expiration. Combined with mucus plugging, this obstruction causes air trapping and hyperinflation, which flattens the diaphragm, reduces tidal volume, and significantly increases the work of breathing.
Q5: How does chronic bronchitis impair gas exchange?
Airway obstruction and mucus plugging create a ventilation-perfusion mismatch where perfusion exceeds ventilation. This mismatch leads to hypoxemia and, in advanced cases, hypercapnia due to poor carbon dioxide clearance. Progressive airway damage reduces the lungs' ability to oxygenate blood and eliminate carbon dioxide effectively.
Q6: What are the main clinical symptoms of chronic bronchitis?
Chronic bronchitis presents with chronic productive cough, dyspnea, and frequent infections. These symptoms result from persistent airway inflammation, excessive mucus production, and impaired clearance mechanisms. Although lung parenchyma is relatively preserved compared to emphysema, progressive airway damage leads to declining lung function and worsening symptoms.
Q7: How does chronic bronchitis differ from emphysema in COPD?
Chronic bronchitis is characterized by airway-centered inflammation and mucus overproduction with relatively preserved lung parenchyma. In contrast, emphysema involves parenchymal destruction. Understanding both phenotypes is essential for recognizing that chronic obstructive pulmonary disease emphysema and chronic bronchitis represent distinct pathological processes within COPD.